ArticleBioinformatics (Oxford, England)2018
RWEN: response-weighted elastic net for prediction of chemosensitivity of cancer cell lines.
Article in Bioinformatics (Oxford, England), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Article
- Trust me if you can: a survey on reliability and interpretability of machine learning approaches for drug sensitivity prediction in cancer.Briefings in bioinformatics · 2024Review
- A comprehensive benchmarking of machine learning algorithms and dimensionality reduction methods for drug sensitivity prediction.Briefings in bioinformatics · 2024Article
- A novel prognostic signature related to programmed cell death in osteosarcoma.Frontiers in immunology · 2024Article
- NeuPD-A Neural Network-Based Approach to Predict Antineoplastic Drug Response.Diagnostics (Basel, Switzerland) · 2023Article
- Predicting heterogeneity in clone-specific therapeutic vulnerabilities using single-cell transcriptomic signatures.Genome medicine · 2021Article
- Soft threshold partial least squares predicts the survival fraction of malignant glioma cells against different concentrations of methotrexate's derivatives.Scientific reports · 2021Article
- A Gene Expression Signature to Predict Nucleotide Excision Repair Defects and Novel Therapeutic Approaches.International journal of molecular sciences · 2021Article
- PRoBE the cloud toolkit: finding the best biomarkers of drug response within a breast cancer clinical trial.JAMIA open · 2021Article
- Article
- Automatic discovery of 100-miRNA signature for cancer classification using ensemble feature selection.BMC bioinformatics · 2019Article
- Computational Analyses Connect Small-Molecule Sensitivity to Cellular Features Using Large Panels of Cancer Cell Lines.Methods in molecular biology (Clifton, N.J.) · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Motivation: In recent years there have been several efforts to generate sensitivity profiles of collections of genomically characterized cell lines to panels of candidate therapeutic compounds. These data provide the basis for the development of in silico models of sensitivity based on cellular, genetic, or expression biomarkers of cancer cells. However, a remaining challenge is an efficient way to identify accurate sets of biomarkers to validate. To address this challenge, we developed methodology using gene-expression profiles of human cancer cell lines to predict the responses of these cell lines to a panel of compounds. Results: We developed an iterative weighting scheme which, when applied to elastic net, a regularized regression method, significantly improves the overall accuracy of predictions, particularly in the highly sensitive response region. In addition to application of these methods to actual chemical sensitivity data, we investigated the effects of sample size, number of features, model sparsity, signal-to-noise ratio, and feature correlation on predictive performance using a simulation framework, particularly for situations where the number of covariates is much larger than sample size. While our method aims to be useful in therapeutic discovery and understanding of the basic mechanisms of action of drugs and their targets, it is generally applicable in any domain where predictions of extreme responses are of highest importance. Availability and implementation: The iterative and other weighting algorithms were implemented in R. The code is available at https://github.com/kiwtir/RWEN. The CTRP data are available at ftp://caftpd.nci.nih.gov/pub/OCG-DCC/CTD2/Broad/CTRPv2.1_2016_pub_NatChemBiol_12_109/ and the Sanger data at ftp://ftp.sanger.ac.uk/pub/project/cancerrxgene/releases/release-6.0/. Supplementary information: Supplementary data are available at Bioinformatics online.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.